Stoke Therapeutics, Inc.
STOKNASDAQHealthcare● Active
$29.00
$-1.01(-3.37%)
Market Cap$1.8B
P/E Ratio—
52W High$40.22
52W Low$10.635
Stoke Therapeutics, Inc.（STOK）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · STOK · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.18B | $0.04B | $0.01B | $0.01B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.18B | $0.04B | $0.01B | $0.01B | $0.00B |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.14B | $0.09B | $0.08B | $0.08B | $0.05B |
| G&A Expenses | $0.07B | $0.05B | $0.04B | $0.04B | $0.03B |
| Total Operating Expenses | $0.21B | $0.14B | $0.12B | $0.12B | $0.09B |
| Operating Income | ($0.02B) | ($0.10B) | ($0.11B) | ($0.10B) | ($0.09B) |
| Operating Margin %(computed) | -11.16% | -277.31% | — | -841.24% | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.09B) | ($0.10B) | ($0.10B) | ($0.09B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.09B) | ($0.10B) | ($0.10B) | ($0.09B) |
| Net Margin %(computed) | -3.73% | -243.42% | — | -814.73% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.12 | $-1.65 | $-2.38 | $-2.60 | $-2.34 |
| Wtd Avg Shares | 0.06B | 0.05B | 0.04B | 0.04B | 0.04B |
| EBITDA | ($0.02B) | ($0.10B) | ($0.11B) | ($0.10B) | ($0.09B) |
| EBITDA Margin %(computed) | -10.20% | -271.36% | — | -828.78% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Stoke Therapeutics, Inc.
关于Stoke Therapeutics, Inc.（STOK）损益表
Stoke Therapeutics, Inc.（STOK）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，STOK实现营收$0.18B，毛利润$0.18B（毛利率100.00%），净利润($0.01B)（净利率-3.73%）。
常见问题
STOK · 4 问Stoke Therapeutics, Inc.（STOK）2025财年营收为$0.18B，同比up404.5%。
STOK revenueSTOK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08